Globus Medical, Inc.GMEDNYSE
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank72
3Y CAGR+66.7%
5Y CAGR-0.7%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+66.7%/yr
Quarterly compound
5Y CAGR
-0.7%/yr
Recent acceleration
Percentile
P72
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 19.32% |
| Q3 2025 | -41.33% |
| Q2 2025 | 172.73% |
| Q1 2025 | 189.47% |
| Q4 2024 | -50.00% |
| Q3 2024 | 65.22% |
| Q2 2024 | 537.26% |
| Q1 2024 | -147.82% |
| Q4 2023 | 1150.00% |
| Q3 2023 | -98.46% |
| Q2 2023 | 16.33% |
| Q1 2023 | -2.00% |
| Q4 2022 | 4.17% |
| Q3 2022 | -11.11% |
| Q2 2022 | 45.95% |
| Q1 2022 | 146.67% |
| Q4 2021 | -68.09% |
| Q3 2021 | 14.63% |
| Q2 2021 | -8.89% |
| Q1 2021 | -16.67% |
| Q4 2020 | 20.00% |
| Q3 2020 | 314.29% |
| Q2 2020 | -180.77% |
| Q1 2020 | -43.48% |
| Q4 2019 | 17.95% |
| Q3 2019 | 0.00% |
| Q2 2019 | 14.71% |
| Q1 2019 | -8.11% |
| Q4 2018 | 2.78% |
| Q3 2018 | -21.74% |
| Q2 2018 | 12.20% |
| Q1 2018 | 64.00% |
| Q4 2017 | -7.41% |
| Q3 2017 | -10.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 20.00% |
| Q4 2016 | -7.41% |
| Q3 2016 | 0.00% |
| Q2 2016 | -6.90% |
| Q1 2016 | -25.64% |